Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
09/27/1995 | CN1108949A Instant powder made from fresh dendrobe |
09/27/1995 | CN1108946A Tincture for toothache and its preparation |
09/27/1995 | CN1108942A Medicine for external use on skins in summer and its preparation |
09/27/1995 | CN1108931A Rapamycin formulations for oral administration |
09/27/1995 | CN1108930A Soft gelatin capsule manufacture |
09/27/1995 | CN1108929A Sugar-coated pharmaceutical dosage unit |
09/27/1995 | CN1108928A One-step process for producing polyvinyl pyrrolidone-iodine aerosol |
09/27/1995 | CN1108927A Silica ketoconazole ointment and its preparation |
09/27/1995 | CN1108926A Suppository for women health |
09/27/1995 | CN1029820C Preparation of common threewingnut root extract dressed by beta-cyclodextrin |
09/26/1995 | US5453447 Preparation of stable injectable β-carotene solubilizates |
09/26/1995 | US5453445 Lidocaine free base and phenylephrine hydrochloride dissolved in specified fluorinated ethane and propane solvents |
09/26/1995 | US5453435 Preservative system for contact lens solutions |
09/26/1995 | US5453425 Risperidone oral formulation |
09/26/1995 | US5453368 Method of encapsulating biological substances in microspheres |
09/26/1995 | US5453284 Thickener prevents activation of oxidoreductase enzyme prior to application |
09/26/1995 | US5453283 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation |
09/26/1995 | US5453281 Binder excipients in tablets |
09/26/1995 | US5453280 Suspension with stirring in water immiscible nonsolvent; sustained release |
09/26/1995 | US5453279 Enhancing transdermal absorption compositions; transdermal dosage form; and process |
09/24/1995 | CA2142653A1 Pharmaceutical composition |
09/23/1995 | CA2143515A1 Method for enhancing the rate of skin permeation of lactic acid through use of the l-enantiomer |
09/23/1995 | CA2142940A1 Method and composition having enhanced alpha-hydroxy skin permeation and retention |
09/22/1995 | CA2144917A1 Time-released alfuzosin hydrochloride galenical forms |
09/21/1995 | WO1995025287A1 Material to be worn on the eyeball |
09/21/1995 | WO1995025084A1 A method of rendering organic compounds soluble in fatty systems, novel chemical complexes of such compounds and various applications of the complexes |
09/21/1995 | WO1995024930A1 Use of green porphyrins in ocular diagnosis and therapy |
09/21/1995 | WO1995024929A2 Polymeric gene delivery system |
09/21/1995 | WO1995024915A1 Product and process for regulating signal transduction pathways |
09/21/1995 | WO1995024908A1 Use of nitric oxide-releasing polymers to treat restenosis and related disorders |
09/21/1995 | WO1995024893A1 Delivery systems for hydrophobic drugs |
09/21/1995 | WO1995024892A1 Aerosol drug formulations containing vitamin e |
09/21/1995 | WO1995024891A1 Topical thalidomide compositions for surface or mucosal wounds, ulcerations, and lesions |
09/21/1995 | WO1995024890A1 Method for making chewable tablets based on troxerutine, calcium carbonate, calcium phosphate, arginine aspartate, arginine glutamate, amoxicillin, a combination of calcium carbonate and magnesium carbonate, and a combination of aluminium hydroxide and magnesium hydroxide |
09/21/1995 | WO1995024889A1 Inhalation composition containing lactose pellets |
09/21/1995 | WO1995024832A1 Stable, optically clear compositions |
09/21/1995 | WO1995022974A3 Film coated tablet of paracetamol and domperidone |
09/21/1995 | DE4410637C1 Injizierbare Lösungen von Dirithromycin Injectable solutions of dirithromycin |
09/21/1995 | DE4409072A1 Filling for sticking plasters having a dermatological curative effect |
09/21/1995 | CA2190121A1 Polymeric gene delivery system |
09/21/1995 | CA2185690A1 Method for making chewable tablets based on troxerutine, calcium carbonate, calcium phosphate, arginine aspartate, arginine glutamate, amoxicillin, a combination of calcium carbonate and magnesium carbonate, and a combination of aluminium hydroxide and magnesium hydroxide |
09/21/1995 | CA2185584A1 Stable, optically clear compositions |
09/21/1995 | CA2184631A1 Product and process for regulating signal transduction pathways |
09/21/1995 | CA2183557A1 Aerosol drug formulations containing vitamin e |
09/21/1995 | CA2162394A1 Material to be worn on the eyeball |
09/20/1995 | EP0672682A1 hPTH(1-36) peptides, their preparation and pharmaceutical compositions |
09/20/1995 | EP0672422A1 Antiinflammatory and analgesic transdermal gel |
09/20/1995 | EP0672416A1 Pharmaceutical composition comprising diamorphine |
09/20/1995 | EP0672414A2 Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen |
09/20/1995 | EP0672410A1 Silicon vesicles and entrapment |
09/20/1995 | EP0672406A1 Composition based on alpha-pyrones for inducing and stimulating hair growth and/or inhibit loss, and its use |
09/20/1995 | EP0671952A1 Method for nonspecific cellular immune stimulation |
09/20/1995 | EP0671950A1 Immunological purging of tumor cells from bone marrow using microspheres and monoclonal antibodies |
09/20/1995 | EP0671942A1 Medical use, a medical method and a pharmaceutical preparation |
09/20/1995 | EP0671937A1 Pharmaceutical emulsion compositions |
09/20/1995 | EP0671929A1 Compositions |
09/20/1995 | EP0671927A1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
09/20/1995 | EP0671919A1 Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it |
09/20/1995 | EP0671916A1 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer |
09/20/1995 | EP0671912A1 Injectable taxane derivative based compositions |
09/20/1995 | EP0671908A1 Pharmaceutical compositions comprising 5-ht 1? receptor agonists and absorption enhancers |
09/20/1995 | EP0671907A1 Composition and method for inducing satiety |
09/20/1995 | EP0671906A1 Bioadhesive microspheres and their use as drug delivery and imaging systems |
09/20/1995 | EP0671905A1 Stable protein: phospholipid compositions and methods |
09/20/1995 | EP0671904A1 Antibiotic formulation and use for drug resistant infections |
09/20/1995 | EP0671903A1 Topical and transdermal delivery system utilizing submicron oil spheres |
09/20/1995 | EP0671901A1 Compositions for dispensing fragrances |
09/20/1995 | EP0620731B1 Pharmaceutical preparation in the form of an effervescent and/or disintegrating tablet or an instant granulate, and process for producing it |
09/20/1995 | EP0614356B1 Transdermal estradiol delivery system |
09/20/1995 | EP0584315B1 Cosmetic and/or pharmaceutical composition containing a dispersion of lipidic vesicles, process for the preparation of said dispersion, and lipidic vesicle dispersion |
09/20/1995 | EP0526476B1 Chemical tablet with central hole and partially exposed top and bottom |
09/20/1995 | CN1108662A Method of producing reconstituted lipoproteins |
09/20/1995 | CN1108575A Oil-based and water-based adjuvant mixture |
09/20/1995 | CN1108571A "Youshengling" for giving a good birth |
09/20/1995 | CN1108570A "Yuntongshu" capsule for curing areolar-ache and its preparation method |
09/20/1995 | CN1108567A Cordate houttuynia nutrient oral liquor |
09/20/1995 | CN1108566A Liniment for treatment of osteoproliferation |
09/20/1995 | CN1108565A Pennisetum flaccidum nasal-drops and preparation method thereof |
09/20/1995 | CN1108558A "Shenmai"-a medicine (pill or tablet) made from ginseng rootlets and ophiopogon root |
09/20/1995 | CN1108555A Medicine for curing tenosynovitis and preparation method thereof |
09/20/1995 | CN1108552A Medicinal liquid for curing toothache and preparation method thereof |
09/20/1995 | CN1108546A Sour-sweet gum anthelminthic tablet |
09/20/1995 | CN1108543A "Houjiling"-medicine made from plum and apricot for curing throat disease and production method thereof |
09/20/1995 | CN1108541A "Fengjiaoshuang"-medicine for curing dermatitis |
09/20/1995 | CN1108535A Heart basal liquid and preparation technology thereof |
09/20/1995 | CN1108534A Synergistic gastrointestinal formulations |
09/20/1995 | CN1108532A 皮肤癌治疗 Skin Cancer Treatment |
09/20/1995 | CN1108531A Gastrointestinal cancer treatment |
09/20/1995 | CN1108529A Rapamycin formulations for oral administration |
09/20/1995 | CN1108526A Gastrointestinal treatment |
09/20/1995 | CN1108511A Drying systems for apparatus for gelatin coating tablets |
09/20/1995 | CN1108472A Solid insecticidal formulation |
09/20/1995 | CN1029770C Controlled release bases for pharmaceuticals |
09/19/1995 | US5451661 Process for making lipid conjugates |
09/19/1995 | US5451609 Deacetly moxisylyte |
09/19/1995 | US5451572 Human relaxin formulation |
09/19/1995 | US5451569 No micelles or liposomes |
09/19/1995 | US5451411 Polyacrylic acid, crosslinked alginate |
09/19/1995 | US5451410 Modified amino acids for encapsulating active agents |
09/19/1995 | US5451409 Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends |